{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:34Z","timestamp":1789010014174,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T00:00:00Z","timestamp":1318896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T00:00:00Z","timestamp":1318896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/leu.2011.254","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T10:40:49Z","timestamp":1318934449000},"page":"633-643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity"],"prefix":"10.1038","volume":"26","author":[{"given":"L","family":"Grkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pulanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E W","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F T","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K J","family":"Martires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D N","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T N","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Salit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S D","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Z","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,18]]},"reference":[{"key":"BFleu2011254_CR1","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.leu.2403856","volume":"19","author":"DJ Weisdorf","year":"2005","unstructured":"Weisdorf DJ . Chronic graft-versus-host disease: where is promise for the future? Leukemia 2005; 19: 1532\u20131535.","journal-title":"Leukemia"},{"key":"BFleu2011254_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood.V100.2.406","volume":"100","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406\u2013414.","journal-title":"Blood"},{"key":"BFleu2011254_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/leu.2010.187","volume":"24","author":"S Thepot","year":"2010","unstructured":"Thepot S, Zhou J, Perrot A, Robin M, Xhaard A, de Latour RP et al. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation. Leukemia 2010; 24: 1852\u20131858.","journal-title":"Leukemia"},{"key":"BFleu2011254_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1017\/CBO9780511576751","volume-title":"Chronic Graft Versus Host Disease Interdisciplinary Management","author":"G Vogelsang","year":"2009","unstructured":"Vogelsang G, Pavletic S . Clinical manifestations and natural history. In: Flowers M, Vogelsang G (eds). Chronic Graft Versus Host Disease Interdisciplinary Management. Cambrige University Press: New York, NY, 2009, pp 56\u201369."},{"key":"BFleu2011254_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/leu.2008.276","volume":"23","author":"BS Cho","year":"2009","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23: 78\u201384.","journal-title":"Leukemia"},{"key":"BFleu2011254_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/10428199509051718","volume":"17","author":"V Barak","year":"1995","unstructured":"Barak V, Levi-Schaffer F, Nisman B, Nagler A . Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 1995; 17: 169\u2013173.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011254_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/bmt.2009.80","volume":"44","author":"C Skert","year":"2009","unstructured":"Skert C, Damiani D, Michelutti A, Patriarca F, Arpinati M, Fili C et al. Kinetics of Th1\/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant 2009; 44: 729\u2013737.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2011254_CR8","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1182\/blood-2007-08-106286","volume":"111","author":"H Fujii","year":"2008","unstructured":"Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 2008; 111: 3276\u20133285.","journal-title":"Blood"},{"key":"BFleu2011254_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448\u2013454.","journal-title":"N Engl J Med"},{"key":"BFleu2011254_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u2013233.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00007890-199901150-00009","volume":"67","author":"LM Liem","year":"1999","unstructured":"Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E . Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999; 67: 59\u201365.","journal-title":"Transplantation"},{"key":"BFleu2011254_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00062752-199801000-00004","volume":"5","author":"R Parkman","year":"1998","unstructured":"Parkman R . Chronic graft-versus-host disease. Curr Opin Hematol 1998; 5: 22\u201325.","journal-title":"Curr Opin Hematol"},{"key":"BFleu2011254_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/sj.bmt.1704151","volume":"32","author":"J Seconi","year":"2003","unstructured":"Seconi J, Watt V, Ritchie DS . Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 2003; 32: 447\u2013450.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2011254_CR14","first-page":"224","volume":"9","author":"RK Mallya","year":"1982","unstructured":"Mallya RK, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB . Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982; 9: 224\u2013228.","journal-title":"J Rheumatol"},{"key":"BFleu2011254_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1346-8138.2010.00883.x","volume":"37","author":"T Ohtsuka","year":"2010","unstructured":"Ohtsuka T . Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis. J Dermatol 2010; 37: 801\u2013806.","journal-title":"J Dermatol"},{"key":"BFleu2011254_CR16","first-page":"477","volume":"72","author":"MM Glovsky","year":"1994","unstructured":"Glovsky MM . Applications of complement determinations in human disease. Ann Allergy 1994; 72: 477\u2013486; quiz 486\u2013490.","journal-title":"Ann Allergy"},{"key":"BFleu2011254_CR17","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/art.24316","volume":"59","author":"S Gaitonde","year":"2008","unstructured":"Gaitonde S, Samols D, Kushner I . C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 2008; 59: 1814\u20131820.","journal-title":"Arthritis Rheum"},{"key":"BFleu2011254_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1701286","volume":"22","author":"R Schots","year":"1998","unstructured":"Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant 1998; 22: 79\u201385.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2011254_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.0902-4441.2005.00568.x","volume":"76","author":"M Pihusch","year":"2006","unstructured":"Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76: 93\u2013101.","journal-title":"Eur J Haematol"},{"key":"BFleu2011254_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bmt.2009.238","volume":"45","author":"SA Mitchell","year":"2010","unstructured":"Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010; 45: 762\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2011254_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","volume":"12","author":"SZ Pavletic","year":"2006","unstructured":"Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252\u2013266.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","volume":"8","author":"S Lee","year":"2002","unstructured":"Lee S, Cook EF, Soiffer R, Antin JH . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444\u2013452.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","volume":"51","author":"JE Ware Jr","year":"1998","unstructured":"Ware Jr JE, Gandek B . Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903\u2013912.","journal-title":"J Clin Epidemiol"},{"key":"BFleu2011254_CR25","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W","volume":"69","author":"MM Schubert","year":"1992","unstructured":"Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK . Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992; 69: 2469\u20132477.","journal-title":"Cancer"},{"key":"BFleu2011254_CR26","first-page":"189","volume-title":"Nonparametric Statistical Methods","author":"M Hollander","year":"1999","unstructured":"Hollander M, Wolfe DA . Nonparametric Statistical Methods, 2nd edn. Wiley: New York, NY, 1999, pp 189\u2013269."},{"key":"BFleu2011254_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","volume":"28","author":"PJ Martin","year":"2010","unstructured":"Martin PJ, Counts Jr GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011\u20131016.","journal-title":"J Clin Oncol"},{"key":"BFleu2011254_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbmt.2010.06.018","volume":"17","author":"PJ Martin","year":"2011","unstructured":"Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers ME, Gupta V et al. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011; 17: 124\u2013132.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-0-387-78580-6_12","volume":"144","author":"PJ Martin","year":"2009","unstructured":"Martin PJ, Pavletic SZ . Biology and management of chronic graft-versus-host disease. Cancer Treat Res 2009; 144: 277\u2013298.","journal-title":"Cancer Treat Res"},{"key":"BFleu2011254_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.beha.2010.09.016","volume":"23","author":"SJ Lee","year":"2010","unstructured":"Lee SJ . Have we made progress in the management of chronic graft-vs-host disease? Best Pract Res Clin Haematol 2010; 23: 529\u2013535.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu2011254_CR31","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbmt.2008.09.017","volume":"14","author":"ME Flowers","year":"2008","unstructured":"Flowers ME, Storer B, Carpenter P, Rezvani AR, Vigorito AC, Campregher PV et al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14: 1380\u20131384.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.beha.2008.03.001","volume":"21","author":"PJ Martin","year":"2008","unstructured":"Martin PJ . Study design and endpoints in graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 357\u2013372.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu2011254_CR33","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1056\/NEJM200504143521525","volume":"352","author":"S Woloshin","year":"2005","unstructured":"Woloshin S, Schwartz LM . Distribution of C-reactive protein values in the United States. N Engl J Med 2005; 352: 1611\u20131613.","journal-title":"N Engl J Med"},{"key":"BFleu2011254_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","volume":"43","author":"EM Macy","year":"1997","unstructured":"Macy EM, Hayes TE, Tracy RP . Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52\u201358.","journal-title":"Clin Chem"},{"key":"BFleu2011254_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.amjmed.2005.06.057","volume":"119","author":"I Kushner","year":"2006","unstructured":"Kushner I, Rzewnicki D, Samols D . What does minor elevation of C-reactive protein signify? Am J Med 2006; 119: 166 e117\u2013128.","journal-title":"Am J Med"},{"key":"BFleu2011254_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0049-0172(05)80003-4","volume":"24","author":"IG Otterness","year":"1994","unstructured":"Otterness IG . The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 1994; 24: 91\u2013104.","journal-title":"Semin Arthritis Rheum"},{"key":"BFleu2011254_CR37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/jcp.37.9.1022","volume":"37","author":"SA Walker","year":"1984","unstructured":"Walker SA, Riches PG, Rogers TR, White S, Hobbs JR . Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: late post-transplant period. J Clin Pathol 1984; 37: 1022\u20131026.","journal-title":"J Clin Pathol"},{"key":"BFleu2011254_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3324\/haematol.2010.030874","volume":"96","author":"A Rovo","year":"2011","unstructured":"Rovo A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M et al. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica 2011; 96: 150\u2013155.","journal-title":"Haematologica"},{"key":"BFleu2011254_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2302\/kjm.57.177","volume":"57","author":"PJ Martin","year":"2008","unstructured":"Martin PJ . Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57: 177\u2013183.","journal-title":"Keio J Med"},{"key":"BFleu2011254_CR40","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3109\/08860221003664256","volume":"32","author":"D Kaminska","year":"2010","unstructured":"Kaminska D, Bernat B, Vakulenko O, Kuzniar J, Tyran B, Suchnicki K et al. Glomerular lesion and increased cytokine gene expression in renal tissue in patients with decompensated nephrotic syndrome due to chronic GvHD. Ren Fail 2010; 32: 510\u2013514.","journal-title":"Ren Fail"},{"key":"BFleu2011254_CR41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/01.tp.0000209496.26639.cb","volume":"81","author":"AA Colombo","year":"2006","unstructured":"Colombo AA, Rusconi C, Esposito C, Bernasconi P, Caldera D, Lazzarino M et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006; 81: 1087\u20131092.","journal-title":"Transplantation"},{"key":"BFleu2011254_CR42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/anr.1780321011","volume":"32","author":"G Senaldi","year":"1989","unstructured":"Senaldi G, Lupoli S, Vergani D, Black CM . Activation of the complement system in systemic sclerosis. Relationship to clinical severity. Arthritis Rheum 1989; 32: 1262\u20131267.","journal-title":"Arthritis Rheum"},{"key":"BFleu2011254_CR43","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1016\/j.bbmt.2009.10.013","volume":"16","author":"G Socie","year":"2010","unstructured":"Socie G, Ritz J, Martin PJ . Current challenges in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: S146\u2013S151.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2011254_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/10428190290026268","volume":"43","author":"G Akpek","year":"2002","unstructured":"Akpek G . Clinical grading in chronic graft-versus-host disease: is it time for change? Leuk Lymphoma 2002; 43: 1211\u20131220.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011254_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/bmt.2009.196","volume":"44","author":"D Pulanic","year":"2009","unstructured":"Pulanic D, Lozier JN, Pavletic SZ . Thrombocytopenia and hemostatic disorders in chronic graft versus host disease. Bone Marrow Transplant 2009; 44: 393\u2013403.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2011254_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1381612033391900","volume":"9","author":"H Ito","year":"2003","unstructured":"Ito H . Anti-interleukin-6 therapy for Crohn's disease. Curr Pharm Des 2003; 9: 295\u2013305.","journal-title":"Curr Pharm Des"},{"key":"BFleu2011254_CR47","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","volume":"98","author":"A Kaser","year":"2001","unstructured":"Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98: 2720\u20132725.","journal-title":"Blood"},{"key":"BFleu2011254_CR48","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM199306033282203","volume":"328","author":"MS Anscher","year":"1993","unstructured":"Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL . Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993; 328: 1592\u20131598.","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"BFleu2011254_CR49","doi-asserted-by":"publisher","first-page":"v18","DOI":"10.1093\/rheumatology\/ken267","volume":"47","author":"S Guiducci","year":"2008","unstructured":"Guiducci S, Distler O, Distler JH, Matucci-Cerinic M . Mechanisms of vascular damage in SSc\u2014implications for vascular treatment strategies. Rheumatology (Oxford) 2008; 47 (Suppl 5): v18\u2013v20.","journal-title":"Rheumatology (Oxford)"},{"key":"BFleu2011254_CR50","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1182\/blood-2008-07-168351","volume":"113","author":"MM Imanguli","year":"2009","unstructured":"Imanguli MM, Swaim WD, League SC, Gress RE, Pavletic SZ, Hakim FT . Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa. Blood 2009; 113: 3620\u20133630.","journal-title":"Blood"},{"key":"BFleu2011254_CR51","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1200\/JCO.2010.29.1682","volume":"28","author":"U Gergis","year":"2010","unstructured":"Gergis U, Arnason J, Yantiss R, Shore T, Wissa U, Feldman E et al. Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease. J Clin Oncol 2010; 28: e602\u2013e604.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011254","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:39:45Z","timestamp":1648737585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,18]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFleu2011254"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.254","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,18]]},"assertion":[{"value":"10 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}